RESPONSE BIOMEDICAL CORP·4

Apr 4, 9:59 PM ET

Wang David 4

4 · RESPONSE BIOMEDICAL CORP · Filed Apr 4, 2012

Insider Transaction Report

Form 4
Period: 2012-04-02
Wang David
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-04-02+400,000400,000 total
    Exercise: $0.11Exp: 2022-04-02Common Stock (400,000 underlying)
Footnotes (3)
  • [F1]Exercise prices shown are denominated in Canadian Dollars.
  • [F2]100% of the options vest fully on the date which is one year after the date of grant.
  • [F3]The options granted are subject to approval of shareholders and the Toronto Stock Exchange. If such approvals are not obtained, the options will expire.

Documents

2 files